Karyopharm Therapeutics Inc.
KPTI
$8.02
-$0.36-4.30%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -196.04M | -124.62M | -123.57M | -62.52M | -76.42M |
| Total Depreciation and Amortization | 296.00K | 358.00K | 320.00K | 333.00K | 340.00K |
| Total Amortization of Deferred Charges | 10.55M | 10.46M | 10.06M | 8.73M | 6.37M |
| Total Other Non-Cash Items | 81.56M | -7.73M | -18.17M | -78.18M | -57.47M |
| Change in Net Operating Assets | 28.27M | 32.18M | 28.41M | 8.89M | -302.00K |
| Cash from Operations | -75.37M | -89.35M | -102.94M | -122.75M | -127.49M |
| Capital Expenditure | -- | 53.00K | 53.00K | 53.00K | -142.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 43.38M | 53.12M | 55.79M | 88.77M | 95.62M |
| Cash from Investing | 43.38M | 53.18M | 55.84M | 88.82M | 95.47M |
| Total Debt Issued | 27.25M | 0.00 | 83.30M | 83.30M | 83.30M |
| Total Debt Repaid | -250.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 9.51M | 1.04M | 1.04M | 1.45M | 1.45M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.46M | 0.00 | -83.30M | -43.11M | -43.11M |
| Cash from Financing | 30.05M | 1.04M | 1.04M | 41.65M | 41.65M |
| Foreign Exchange rate Adjustments | 20.00K | -5.00K | 29.00K | 10.00K | -11.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.92M | -35.15M | -46.04M | 7.73M | 9.62M |